Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
PharmaCielo has received a purchase order for CBD Isolate as an API, which will be used by a large pharmaceutical company in Brazil (the "Customer"), for final testing. The Customer has already...
Steady progress against the efficiency plans initiated in mid-2021 with the transition to the current senior management team. Expects a reduction in its annualized fixed costs by approximately 25%...
Ease Labs Pharma, a global pharmaceutical company headquartered in Brazil, has received regulatory approval from the Brazilian Health Regulatory Agency (ANVISA) to launch its Canabidiol Ease Labs 100 ...
Represents PharmaCielo's first shipment to Africa. Morocco is pioneering the commercialization of cannabinoid products on the African continent and will be a growing market. The Company also...
TORONTO and RIONEGRO, Colombia, Nov. 22, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer...
In the first nine months of 2022, PharmaCielo has made shipments to 23 customers in nine countries, with continued growth expected for 2023. The Company has more than doubled Revenue to $3.8 million...
This is PharmaCielo's second pharmaceutical grade product shipment to a well-established Latin American pharmaceutical company with operations in Uruguay. TORONTO and RIONEGRO, Colombia, Oct. 12,...
Shipment made to an established pharmaceutical distributor and clinical research organization in the Czech Republic, focused on medicinal grade cannabinoids TORONTO and RIONEGRO, Colombia, Sept. 15,...
Colombian government has maintained its commitment to supporting its cannabis producers and building a dominant global export industry. Five tonne quota to grow THC-dominant cannabis strains for...
The Company continues to grow sales and expects to build momentum through the remainder of 2022 and through 2023, with recent progress in Israel, Brazil and Mexico. PharmaCielo product has been sold...
The Company expects to begin exporting dried flower to Israel in early 2023. Israel is one of the largest importers of medical cannabis in the world, with 109,352 active medical patients in 2021...
The Company has made a pre-commercial shipment of CBD isolate to its Mexican joint venture, to support product development by a Mexican phytotherapeutic company. TORONTO and RIONEGRO, Colombia , Aug. ...
TORONTO and RIONEGRO, Colombia , July 28, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer ...
The Company has shipped pre-commercial quantities of CBD full spectrum oil containing THC, to support the development of a full spectrum product for the Brazilian market. TORONTO and RIONEGRO,...
The Company expects Revenue to continue to grow – recently shipped 300 kg of CBD Full Spectrum Oil to a Spanish pharmaceutical company, announced entrance into Polish market, and shipments to Germany ...
The Company has shipped pharmaceutical grade CBD full spectrum oil containing THC to Extractions Solutions SL, to support pre-commercial development of a full spectrum product for the European market....
TORONTO and RIONEGRO, Colombia, May 11, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer...
Poland is one of the largest cannabis markets in Europe by patient population, with more than 28,000 prescriptions issued to approximately 10,000 patients in the first nine months of 20211. The...
Regulation to enable dried flower export and expand applications of CBD-based products passed by the Colombian Government on February 22, 2022 PharmaCielo's upstream and downstream scale and quality...
Builds on the passing of Regulation 227 in February, which implemented legal provisions to enable dried flower export and access to additional opportunities for CBD-based products. PharmaCielo...
TORONTO and RIONEGRO, Colombia, March 4, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer...
PharmaCielo expects to begin exporting dried flower in the first half of 2022, with volumes growing through the remainder of the year. The Company's upstream and downstream scale and quality uniquely ...
The Company will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022. This is PharmaCielo's first sales agreement related to...
PharmaCielo is actively working with, and has recently shipped product to, established companies in Argentina, Brazil, Colombia and Paraguay. The Company's sales and technical teams are providing...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.